U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219511) titled 'A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure Wi... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219550) titled 'A Study of MK-1084 in Participants With Hepatic Impairment and Healthy Volunteers (MK-1084-... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219589) titled 'A SAD Study of HM17321 in Healthy Adult Participants' on Oct. 16. Brief Summary: This is a... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219576) titled 'Retifanlimab and Ruxolitinib In Solid Malignancies' on Oct. 20. Brief Summary: The goal of... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219615) titled 'A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urti... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219953) titled 'A Study of Brenipatide in Participants With Alcohol Use Disorder' on Oct. 13. Brief Summar... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219641) titled 'Radicle Clarity RPN: A Study Assessing the Impact of Health and Wellness Products on Cognit... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219940) titled 'A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects' on Oct. 19. Br... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219966) titled 'A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder' on Oct... Read More
U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219927) titled 'Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM... Read More